A Covid-19 mobile testing site in New York. Photo: Bloomberg
A Covid-19 mobile testing site in New York. Photo: Bloomberg
Josephine Ma
Opinion

Opinion

As I see it by Josephine Ma

Omicron threat points to need for independent global vaccine comparison mechanism

  • Fragmented, disparate information from vaccine makers and scientists is making it difficult for policymakers to update Covid-19 strategy
  • Pharmaceuticals and governments should give up balking at comparative research for the common good

A Covid-19 mobile testing site in New York. Photo: Bloomberg
A Covid-19 mobile testing site in New York. Photo: Bloomberg
READ FULL ARTICLE